The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Effect of Estrogen Plus Progestin on Global Cognitive Function in Postmenopausal Women: The Women's Health Initiative Memory Study: A Randomized Controlled Trial
Abstract
CONTEXT: Observational studies have suggested that postmenopausal hormone treatment may improve cognitive function, but data from randomized clinical trials have been sparse and inconclusive. The Women's Health Initiative Memory Study (WHIMS) is an ancillary study of the Women's Health Initiative (WHI) hormone therapy trials. On July 8, 2002, the estrogen plus progestin therapy in the WHI trial was discontinued because of certain increased health risks for women. OBJECTIVE: To determine whether estrogen plus progestin therapy protects global cognitive function in older postmenopausal women. DESIGN, SETTING, AND PARTICIPANTS: A randomized, double-blind, placebo-controlled clinical trial, WHIMS is an ancillary study of geographically diverse, community-dwelling women aged 65 years or older from 39 of 40 clinical centers within the WHI estrogen plus progestin trial that started in June 1995. Of 4894 eligible postmenopausal women aged 65 years or older and free of probable dementia at baseline, 4532 (92.6%) were enrolled in the estrogen plus progestin component of WHIMS. A total of 4381 participants (96.7%) provided at least 1 valid cognitive function score between June 1995 and July 8, 2002. INTERVENTIONS: Participants received either 1 daily tablet containing 0.625 mg of conjugated equine estrogen with 2.5 mg of medroxyprogesterone acetate (n = 2145) or matching placebo (n = 2236). MAIN OUTCOME MEASURE: Global cognitive function measured annually with the Modified Mini-Mental State Examination. RESULTS: The Modified Mini-Mental State Examination mean total scores in both groups increased slightly over time (mean follow-up of 4.2 years). Women in the estrogen plus progestin group had smaller average increases in total scores compared with women receiving placebo (P =.03), but these differences were not clinically important. Removing women by censoring them after adjudicated dementia, mild cognitive impairment, or stroke, and nonadherence to study protocol, did not alter the findings. Prior hormone therapy use and duration of prior use did not affect the interpretation of the results, nor did timing of prior hormone therapy initiation with respect to the final menstrual period. More women in the estrogen plus progestin group had a substantial and clinically important decline (> or =2 SDs) in Modified Mini-Mental State Examination total score (6.7%) compared with the placebo group (4.8%) (P =.008). CONCLUSIONS: Among postmenopausal women aged 65 years or older, estrogen plus progestin did not improve cognitive function when compared with placebo. While most women receiving estrogen plus progestin did not experience clinically relevant adverse effects on cognition compared with placebo, a small increased risk of clinically meaningful cognitive decline occurred in the estrogen plus progestin group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Littell, R. C. (1996) · Medical Entomology and Zoology · Cited by 10,547
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
Moms, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G., Mellits, E. D., & Clark, C. (1989) · Neurology · doi:10.1212/wnl.39.9.1159 · Cited by 4,130
(1987) · PubMed · Cited by 2,657
Design of the Women’s Health Initiative Clinical Trial and Observational Study
(1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00078-0 · Cited by 2,585
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022066 · Cited by 2,313
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225
Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Self-citationGrady, D., Herrington, D., Bittner, V., Blumenthal, R., Davidson, M., Hlatky, M., Hsia, J., Hulley, S., Herd, A., Khan, S., et al. (2002) · JAMA · doi:10.1001/jama.288.1.49 · Cited by 1,930
Prevalence and severity of cognitive impairment with and without dementia in an elderly population
Graham, J. E., Rockwood, K., Beattie, B. L., Eastwood, R., Gauthier, S., Tuokko, H., & McDowell, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01007-6 · Cited by 999
Estrogen Therapy in Postmenopausal Women: Effects on Cognitive Function and Dementia
Yaffe, K., Sawaya, G., Lieberburg, I., & Grady, D. (1998) · JAMA · doi:10.1001/jama.279.9.688 · Cited by 941
Estrogen Actions Throughout the Brain
McEwen, B. (2002) · Recent Progress in Hormone Research · doi:10.1210/rp.57.1.357 · Cited by 915
Goodman, Y., Bruce, A. J., Cheng, B., & Mattson, M. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66051836.x · Cited by 830
The course of adult intellectual development
Schaie, K. W. (1994) · American Psychologist · doi:10.1037/0003-066x.49.4.304 · Cited by 799
Neuroprotection against Oxidative Stress by Estrogens: Structure-Activity Relationship
Behl, C., Skutella, T., Lezoualc’H, F., Post, A., Widmann, M., Newton, C. J., & Holsboer, F. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.4.535 · Cited by 762
Effects of estrogen on memory function in surgically menopausal women
Phillips, S. (1992) · Psychoneuroendocrinology · doi:10.1016/0306-4530(92)90007-t · Cited by 741
Sherwin, B. B. (1988) · Psychoneuroendocrinology · doi:10.1016/0306-4530(88)90060-1 · Cited by 703
Effects of estrogen plus progestin on health-related quality of life
Hays, J., Ockene, J. K., Brunner, R. L., Kotchen, J. M., Manson, J. E., Patterson, R. E., Aragaki, A. K., Shumaker, S. A., Brzyski, R. G., LaCroix, A. Z., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030311 · Cited by 686
Cushman, M., Legault, C., Barrett-Connor, E., Stefanick, M. L., Kessler, C., Judd, H. L., Sakkinen, P. A., & Tracy, R. P. (1999) · Circulation · doi:10.1161/01.cir.100.7.717 · Cited by 660
Self-citationHormone Replacement Therapy and Cognition: Systematic Review and Meta-analysis
LeBlanc, E. S., Janowsky, J., Chan, B. K. S., & Nelson, H. D. (2001) · JAMA · doi:10.1001/jama.285.11.1489 · Cited by 659
Luine, V. N. (1985) · Experimental Neurology · doi:10.1016/0014-4886(85)90108-6 · Cited by 523
Diverse Actions of Ovarian Steroids in the Serotonin Neural System
Bethea, C. L., Lu, N. Z., Gundlah, C., & Streicher, J. M. (2002) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0225 · Cited by 490
Hogervorst, E., Williams, J., Budge, M., Riedel, W., & Jolles, J. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00410-3 · Cited by 439
Estrogen Replacement Therapy and Cognitive Function in Older Women
Barrett-Connor, E. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500200051032 · Cited by 377
Cognitive function in nondemented older women who took estrogen after menopause
Jacobs, D. M., Tang, M.-X., Stern, Y., Sano, M., Marder, K., Bell, K. L., Schofield, P., Dooneief, G., Gurland, B., & Mayeux, R. (1998) · Neurology · doi:10.1212/wnl.50.2.368 · Cited by 332
The Women’s Health Initiative Memory Study (WHIMS)
Shumaker, S. A., Reboussin, B. A., Espeland, M. A., Rapp, S. R., McBee, W. L., Dailey, M., Bowen, D., Terrell, T., & Jones, B. N. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(98)00038-5 · Cited by 321
Self-citationMcDowell, I., Kristjansson, B., Hill, G. B., & Hébert, R. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00060-7 · Cited by 307
Risk Factors for Dementia in the Cardiovascular Health Cognition Study
Kuller, L. H., Lopez, O. L., Newman, A., Beauchamp, N. J., Burke, G., Dulberg, C., Fitzpatrick, A., Fried, L., & Haan, M. N. (2003) · Neuroepidemiology · doi:10.1159/000067109 · Cited by 294
Tombaugh, T. N., McDowell, I., Kristjansson, B., & Hubley, A. M. (1996) · Psychological Assessment · doi:10.1037//1040-3590.8.1.48 · Cited by 294
Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition
Maki, P. M., & Resnick, S. M. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00123-8 · Cited by 289
Resnick, S. M., Maki, P. M., Golski, S., Kraut, M. A., & Zonderman, A. B. (1998) · Hormones and Behavior · doi:10.1006/hbeh.1998.1476 · Cited by 276
Enhanced Verbal Memory in Nondemented Elderly Women Receiving Hormone-Replacement Therapy
Maki, P. M., Zonderman, A. B., & Resnick, S. M. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.227 · Cited by 269
Female Hormones and Thrombosis
Rosendaal, F. R., Helmerhorst, F. M., & Vandenbroucke, J. P. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0202.102318 · Cited by 267
Resnick, S. M., Metter, E. J., & Zonderman, A. B. (1997) · Neurology · doi:10.1212/wnl.49.6.1491 · Cited by 256
Hormone replacement therapy for cognitive function in postmenopausal women
Lethaby, A., Hogervorst, E., Richards, M., Yesufu, A., & Yaffe, K. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003122.pub2 · Cited by 214
Estrogen Replacement Therapy and Cognitive Decline in Older Community Women
Matthews, K., Cauley, J., Yaffe, K., & Zmuda, J. M. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb02563.x · Cited by 208
Cognitive Function in Postmenopausal Women Treated With Raloxifene
Yaffe, K., Krueger, K., Sarkar, S., Grady, D., Barrett-Connor, E., Cox, D. A., & Nickelsen, T. (2001) · Obstetrical and Gynecological Survey · doi:10.1097/00006254-200109000-00018 · Cited by 197
POLOKANTOLA, P. (1998) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00700-x · Cited by 176
Estrogen exposures and memory at midlife: A population-based study of women
Henderson, V. W., Guthrie, J. R., Dudley, E. C., Burger, H. G., & Dennerstein, L. (2003) · Neurology · doi:10.1212/01.wnl.0000059413.75888.be · Cited by 174
Self-citationIssues associated with repeated neuropsychological assessments
McCaffrey, R. J., & Westervelt, H. J. (1995) · Neuropsychology Review · doi:10.1007/bf02214762 · Cited by 171
Larrabee, G. J., & Crook, T. H. (1994) · International Psychogeriatrics · doi:10.1017/s1041610294001663 · Cited by 162
Bland, R. C., & Newman, S. C. (2001) · The Canadian Journal of Psychiatry · doi:10.1177/070674370104600604 · Cited by 159
Rice, M. M., Graves, A. B., McCurry, S. M., Gibbons, L. E., Bowen, J. D., McCormick, W. C., & Larson, E. B. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.11.1641 · Cited by 150
Effects of hormone replacement therapy on cognitive performance in elderly women
Binder, E. F., Schechtman, K. B., Birge, S. J., Williams, D. B., & Kohrt, W. M. (2001) · Maturitas · doi:10.1016/s0378-5122(00)00214-0 · Cited by 137
Hormone replacement therapy and reduced cognitive decline in older women: The Cache County Study
Carlson, M. C., Zandi, P. P., Plassman, B. L., Tschanz, J. T., Welsh-Bohmer, K. A., Steffens, D. C., Bastian, L. A., Mehta, K. M., & Breitner, J. C. S. (2001) · Neurology · doi:10.1212/wnl.57.12.2210 · Cited by 129
Prevalence of age-associated memory impairment and dementia in a rural community.
Coria, F., de Caso, J. Á. G., Minguez, L., Rodríguez‐Artalejo, F., & Clavería, L. E. (1993) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.9.973 · Cited by 116
The women's health initiative estrogen replacement therapy is neurotrophic and neuroprotective
Brinton, R. D., Chen, S., Montoya, M., Hsieh, D., Minaya, J., Kim, J., & Chu, H. P. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00109-3 · Cited by 110
A Prevalence Study of Age-Associated Memory Impairment
Barker, A., Jones, R. W., & Jennison, C. (1995) · The British Journal of Psychiatry · doi:10.1192/bjp.167.5.642 · Cited by 109
Progestogen addition during oestrogen replacement therapy — effects on vasomotor symptoms and mood
Holst, J., Bäckström, T., Hammarbäck, S., & von Schoultz, B. (1989) · Maturitas · doi:10.1016/0378-5122(89)90116-3 · Cited by 105
Österlund, M. K., Grandien, K., Keller, É., & Hurd, Y. L. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751390.x · Cited by 104
Toran‐Allerand, C. D. (1991) · Psychoneuroendocrinology · doi:10.1016/0306-4530(91)90068-5 · Cited by 90
Estrogen and Neural Plasticity
Foy, M., Henderson, V., Berger, T., & Thompson, R. F. (2000) · Current Directions in Psychological Science · doi:10.1111/1467-8721.00081 · Cited by 47
Self-citationHormone therapy and the brain : a clinical perspective on the role of estrogen
Henderson, V. W. (2000) · Cited by 42
Self-citationAnalysis of data from group-randomized trials with repeat observations on the same groups
Murray, D. M., Hannan, P. J., Wolfinger, R. D., Baker, W. L., & Dwyer, J. H. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980730)17:14<1581::aid-sim864>3.0.co;2-n · Cited by 39
Bravo, G., & Hébert, R. (2014) · Neuroepidemiology · doi:10.1159/000368808 · Cited by 37
Cited by
Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Self-citationNational Use of Postmenopausal Hormone Therapy: Annual Trends and Response to Recent Evidence
Hersh, A. L., Stefanick, M. L., & Stafford, R. S. (2004) · JAMA · doi:10.1001/jama.291.1.47 · Cited by 983
Self-citationBushnell, C., McCullough, L. D., Awad, I. A., Chireau, M. V., Fedder, W. N., Furie, K. L., Howard, V. J., Lichtman, J. H., Lisabeth, L. D., Piña, I. L., et al. (2014) · Stroke · doi:10.1161/01.str.0000442009.06663.48 · Cited by 941
Rocca, W. A., Bower, J. H., Maraganore, D. M., Ahlskog, J. E., Grossardt, B. R., de Andrade, M., & Melton, L. J. (2007) · Neurology · doi:10.1212/01.wnl.0000276984.19542.e6 · Cited by 827
Espeland, M. A. (2004) · JAMA · doi:10.1001/jama.291.24.2959 · Cited by 795
Self-citation
Metadata
- Authors
- Rapp, S. R., Espeland, M. A., Shumaker, S. A., Henderson, V. W., Brunner, R. L., Manson, J. E., Gass, M. L. S., Stefanick, M. L., Lane, D. S., Hays, J., Johnson, K. C., Coker, L. H., Dailey, M., Bowen, D., & for the WHIMS Investigators
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2003-05-28
- Volume
- 289
- Issue
- 20
- Pages
- 2663
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2135910109
- Cited by
- 930
- References
- 56
- FWCI
- 69.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.